SARCLISA 20mg/mL concentrate for solution for infusion., CellProtect
ISA-HC-NK
Phase 2 small_molecule active
Quick answer
SARCLISA 20mg/mL concentrate for solution for infusion., CellProtect for Multiple myeloma is a Phase 2 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Multiple myeloma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active